Blog / Archives
Biotech Rally Clipped by Trump Tweet; ACA Makeover Creates Uncertainty…Update-1
Update-1... 10:45 am PST Biotech Rally Resumes tweets on drug pricing are apparently forgotten XBI up 2.63%, IBB up 1.6% Green screen day Smaller cap, clinical stage stocks dominate winners....
Rayno BioBeat 2017 #2: Biotech Breakthrough Rally
2017 Biotech Breakthrough on a Green Screen Day Biotech stocks got a second wind today and the 2017 rally broke through recent tops that have been strong resistance. Our favorite trading pick the...
Biotech ETFs: Fidelity Biotech Fund Outperforms IBB but XBI is Still the Leader
Fidelity Biotech Portfolio (FBIOX) Is Beginning to Show Benefits of Active Management Biotech stocks have outperformed the market YTD despite a bit of a sell-off recently. During the bubblicious...
Rayno Biopharma Portfolio Update: BLUE FMI IBB…Update-1
Update-1... 2/22/17 Dow closed at a record 20,775.6 with energy the big loser, healthcare down 0.19% and NASDAQ flattish. Biotech stocks sold off with the IBB down 0.85% after hitting $296 near a 52...
Biotech Recap: Rally Continues with Strong Tape…Update-1
Update-1 2/16... Profit Taking Day-Momentum Eases IBB,XBI down ~0.65% Large caps mixed: AMGN,GILD,MRK,RHHBY in green; REGN down 2.86%. Alexion (ALXN) down 1.22% on earnings and guidance. Misses on...
Large Cap Biopharmaceuticals:Update on Financial Metrics
Top Biopharmaceutical Stocks : Performance and Financial Metrics after 2016 Earnings We have updated the comparison of eight large cap biopharma stocks post 2016 earnings for the period ending...
Rayno Biobeat 2017 #1: Biotech Rally Driven By M&A
Update-1... 1:45p EST Biotech Rally Biogen (BIIB) looking good in here at $275+, up 4.2% over five days, down 2.7% YTD. IBB and XBI slight gains. ======== Biotech Rally Takes Levels to January Top...
More Drug Pricing Headwinds for Biotech Just as Tape Improves: Update-1 M&A Uptick
Update 2/8/17 12N EST Biotech Stocks Perk Up on M&A Rumors PARP Inhibitor stocks- Clovis Oncology (CLVS) up 3%, Tesaro (TSRO) up 12.5%. IBB and XBI flattish. EXEL up 2.7%. INCY up 1.78%. GWPH up...
Large Cap Biopharma: January’17 Update-2
2/6/17 1 PM EST Mid-Caps Outperform in 2017 We will update the metrics and performance of "Large Cap Biopharma" after earnings from Gilead Sciences (GILD) and Regeneron (REGN) tomorrow. The XBI is...
Biotech Blahs Worsened By Political Distractions…Updates
Update: 1/31/17 Biotechs rallying in midday trading afterTrump meeting. Looks like a good time to add positions like CELG IBB and XBI. Mid-Caps are strong-ALNY TSRO SGEN. Dx and Tools- DHR TMO good...